Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort.

PloS one - 7 Oct 2010

Bartmeyer Barbara, Kuecherer Claudia, Houareau Claudia, Werning Johanna, Keeren Kathrin, Somogyi Sybille, Kollan Christian, Jessen Heiko, Dupke Stephan, Hamouda Osamah

Abstract excerpt

BACKGROUND: The aim of this study is to analyse the prevalence of transmitted drug resistance, TDR, and the impact of TDR on treatment success in the German HIV-1 Seroconverter Cohort. METHODS: Genotypic resistance analysis was performed in treatment-naïve study patients whose sample was available 1,312/1,564 (83.9% October 2008). A genotypic resistance result was obtained for 1,276/1,312 (97.3%). The resistance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germany

Share to HIV/AIDS drug development and treatment

Share to HIV Infections

Share to HIV Research and Treatment

Share to Reverse Transcriptase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 20949104
DOI: 10.1371/journal.pone.0012718
PMCID: PMC2951346

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort.PMID 20949104Read ↗

First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study.Semantic proximity Read ↗

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study CohortSemantic proximity Read ↗

Epidemiology of transmitted drug resistance in chronically HIV-infected patients in Germany: the RESINA study 2001-2009.Semantic proximity Read ↗

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.Semantic proximity Read ↗

Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study.Semantic proximity Read ↗

Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.Semantic proximity Read ↗

Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany.Semantic proximity Read ↗

Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.Semantic proximity Read ↗

Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infectionSemantic proximity Read ↗

Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.Semantic proximity Read ↗

Transmission of drug-resistant HIV-1 in Europe remains limited to single classes.Semantic proximity Read ↗

Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000-2008.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.